Gallbladder Neoplasms: all 255 studies

Page 1 of 3. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.

• Incidental Gallbladder Carcinoma :Incidence and Clinical Significance in Specimens From Routine Cholecystectomies in Sohag LocalityRecruitingNCT07885800
• Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerNot yet recruitingNCT07793253Phase 2
• Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or CholangiocarcinomaRecruitingNCT07780838Phase 2
• AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder CancerNot yet recruitingNCT07767994Phase 2
• IKS04 Regimen in Advanced Solid Tumors That Express CA242Not yet recruitingNCT07738939Phase 1
• Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract CancerRecruitingNCT07641036Phase 1/2
• Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II StudyRecruitingNCT07636824Phase 2
• A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Not yet recruitingNCT07623642Phase 2
• Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract CancerRecruitingNCT07614061Phase 1
• To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid TumorsRecruitingNCT07594964Phase 1
• Outcomes After Liver and Biliary Resection at a High-Volume CenterNot yet recruitingNCT07556835
• TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World CohortNot yet recruitingNCT07454486
• Prospective Evaluation of 68Ga-FAPI PET in Biliary CancersRecruitingNCT07337850
• Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder CancerEnrolling by invitationNCT07310069Phase 2
• A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract CancerNot yet recruitingNCT07269158Phase 1/2
• A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerRecruitingNCT07265674Phase 3
• Study of ACC-1898 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07252661Phase 1
• A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)RecruitingNCT07221253Phase 3
• A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers ScreeningRecruitingNCT07176962
• DESTINY-PANTUMOUR04RecruitingNCT07124000
• Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
• Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract CancerRecruitingNCT07025174Phase 2
• Bile Omics for Diagnosing Indeterminate Biliary StricturesRecruitingNCT07007832
• Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for CancerNot yet recruitingNCT06999512Phase 2/3
• Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)Enrolling by invitationNCT06963060Phase 2
• Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic CholangiocarcinomaEnrolling by invitationNCT06901622Phase 2
• Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder CancerRecruitingNCT06852287Phase 2
• Proteomic Analysis of Patients Undergoing Bariatric SurgeryNot yet recruitingNCT06787807Not applicable
• A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
• Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
• Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)RecruitingNCT06712420Phase 3
• Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary ObstructionEnrolling by invitationNCT06671418Phase 3
• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerRecruitingNCT06282575Phase 3
• Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder CancerNot yet recruitingNCT06276153
• Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)RecruitingNCT06246448Not applicable
• Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
• Radiation Therapy in Unresectable Gall Bladder CancerRecruitingNCT06214572Phase 2/3
• EULAT Eradicate GBCRecruitingNCT06192719
• Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract CancerNot yet recruitingNCT06134193Phase 2
• STALL vs Sole Local Wound Infiltration in Laparoscopic CholecystectomyRecruitingNCT06123117Not applicable
• Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)RecruitingNCT06101277Not applicable
• Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder CancerEnrolling by invitationNCT06061744
• Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBCRecruitingNCT06013943Phase 2
• A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder CancerNot yet recruitingNCT05919095Phase 2
• The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract DiseasesNot yet recruitingNCT05896956
• DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsRecruitingNCT05786716Phase 2/3
• Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder CancerRecruitingNCT05757336Phase 2
• NGS in Gallbladder Cancer and Response to TreatmentRecruitingNCT05404347
• Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal MetastasesRecruitingNCT05285358Phase 1
• Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder CancerRecruitingNCT05184400
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesRecruitingNCT05000294Phase 1/2
• Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/2
• Hepatobiliary Tumors Tissue Samples AcquisitionRecruitingNCT04445532
• Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNARecruitingNCT04183712Phase 2
• Chinese Research Group of Gallbladder CancerRecruitingNCT04140552
• Quebec Pancreas Cancer StudyRecruitingNCT04104230
• Multicenter Prospective Cohort Study of Risk Factors for Gallbladder CancerNot yet recruitingNCT03762837
• The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder CancerRecruitingNCT03637569
• The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder CancerRecruitingNCT02920554Not applicable
• Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
• A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsCompletedNCT05712356Phase 2Results posted
• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)CompletedNCT05007106Phase 2Results posted
• Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract CancerActive, not recruitingNCT04941287Phase 2Results posted
• Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension StudyCompletedNCT04924062Phase 3Results posted
• A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid TumorsCompletedNCT04853017Phase 1Results posted
• A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract CancersCompletedNCT04466891Phase 2Results posted
• Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersActive, not recruitingNCT04430738Phase 2Results posted
• Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsTerminatedNCT04383210Phase 2Results posted
• Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)TerminatedNCT04203160Phase 1/2Results posted
• Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract CancerCompletedNCT04072445Phase 2Results posted
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTCTerminatedNCT04066491Phase 2/3Results posted
• Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)CompletedNCT04003636Phase 3Results posted
• M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)CompletedNCT03833661Phase 2Results posted
• Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersCompletedNCT03768414Phase 3Results posted
• TAS-102 in Treating Advanced Biliary Tract CancersCompletedNCT03278106Phase 2Results posted
• Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)CompletedNCT03111732Phase 2Results posted
• Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by SurgeryCompletedNCT02520141Phase 2Results posted
• Programs To Support You During ChemotherapyCompletedNCT02489422Not applicableResults posted
• Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary CancersCompletedNCT02392637Phase 2Results posted
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
• Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by SurgeryCompletedNCT02042443Phase 2Results posted
• MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by SurgeryCompletedNCT01425879Phase 2Results posted
• Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder CancerCompletedNCT01308840Phase 2Results posted
• Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersTerminatedNCT01229111Phase 2Results posted
• Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver TransplantationTerminatedNCT01151761Phase 2Results posted
• Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT01093222Phase 2Results posted
• A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract CancerTerminatedNCT00955721Phase 1/2Results posted
• Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic TherapyCompletedNCT00919061Phase 2Results posted
• Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted
• Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersTerminatedNCT00832637Phase 2Results posted
• S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctCompletedNCT00789958Phase 2Results posted
• Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract CancerCompletedNCT00753675Phase 2Results posted
• A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersCompletedNCT00660699Phase 2Results posted
• Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by SurgeryTerminatedNCT00478140Phase 2Results posted
• Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
• Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerCompletedNCT00361231Phase 2Results posted
• Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary TumorsCompletedNCT00356889Phase 2Results posted
• Oxaliplatin and Capecitabine in Patients With Unresectable CholangiocarcinomaCompletedNCT00338988Phase 2Results posted
• Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract CancerCompletedNCT00107536Phase 2Results posted

← Gallbladder Neoplasms overview